|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD, Goding Sauer A,
Fedewa SA, Butterly LF, Anderson JC, Cercek A, Smith RA and Jemal
A: Colorectal cancer statistics, 2020. CA Cancer J Clin.
70:145–164. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mitry E, Guiu B, Cosconea S, Jooste V,
Faivre J and Bouvier AM: Epidemiology, management and prognosis of
colorectal cancer with lung metastases: A 30-year population-based
study. Gut. 59:1383–1388. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dekker E and Rex DK: Advances in CRC
prevention: Screening and surveillance. Gastroenterology.
154:1970–1984. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tol J, Koopman M, Cats A, Rodenburg CJ,
Creemers GJ, Schrama JG, Erdkamp FL, Vos AH, van Groeningen CJ,
Sinnige HA, et al: Chemotherapy, bevacizumab, and cetuximab in
metastatic colorectal cancer. N Engl J Med. 360:563–572. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ponting CP, Oliver PL and Reik W:
Evolution and functions of long noncoding RNAs. Cell. 136:629–641.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kung JT, Colognori D and Lee JT: Long
noncoding RNAs: Past, present, and future. Genetics. 193:651–669.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Quinn JJ and Chang HY: Unique features of
long non-coding RNA biogenesis and function. Nat Rev Genet.
17:47–62. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Schwarzmueller L, Bril O, Vermeulen L and
Léveillé N: Emerging role and therapeutic potential of lncRNAs in
colorectal cancer. Cancers (Basel). 12:38432020. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Talebi A, Azizpour M, Agah S, Masoodi M,
Mobini GR and Akbari A: The relevance of long noncoding RNAs in
colorectal cancer biology and clinical settings. J Cancer Res Ther.
16 (Suppl):S22–S33. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Srinivasan S, Selvan ST, Archunan G,
Gulyas B and Padmanabhan P: MicroRNAs -the next generation
therapeutic targets in human diseases. Theranostics. 3:930–942.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shukla GC, Singh J and Barik S: MicroRNAs:
Processing, maturation, target recognition and regulatory
functions. Mol Cell Pharmacol. 3:83–92. 2011.PubMed/NCBI
|
|
13
|
Wen XQ, Qian XL, Sun HK, Zheng LL, Zhu WQ,
Li TY and Hu JP: MicroRNAs: multifaceted regulators of colorectal
cancer metastasis and clinical applications. Onco Targets Ther.
13:10851–10866. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ahadi A: The significance of microRNA
deregulation in colorectal cancer development and the clinical uses
as a diagnostic and prognostic biomarker and therapeutic agent.
Noncoding RNA Res. 5:125–134. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Weidle UH, Brinkmann U and Auslaender S:
microRNAs and corresponding targets involved in metastasis of
colorectal cancer in preclinical in vivo models. Cancer Genomics
Proteomics. 17:453–468. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang L, Cho KB, Li Y, Tao G, Xie Z and Guo
B: Long noncoding RNA (lncRNA)-mediated competing endogenous RNA
networks provide novel potential biomarkers and therapeutic targets
for colorectal cancer. Int J Mol Sci. 20:57582019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Guo C, Gao YY, Ju QQ, Zhang CX, Gong M and
Li ZL: LINC00649 underexpression is an adverse prognostic marker in
acute myeloid leukemia. BMC Cancer. 20:8412020. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
He M, Lin Y and Xu Y: Identification of
prognostic biomarkers in colorectal cancer using a long non-coding
RNA-mediated competitive endogenous RNA network. Oncol Lett.
17:2687–2694. 2019.PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Deng M, Bragelmann J, Schultze JL and
Perner S: Web-TCGA: An online platform for integrated analysis of
molecular cancer data sets. BMC Bioinformatics. 17:722016.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hon KW, Abu N, Ab Mutalib NS and Jamal R:
miRNAs and lncRNAs as predictive biomarkers of response to FOLFOX
therapy in colorectal cancer. Front Pharmacol. 9:8462018.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Rivandi M, Pasdar A, Hamzezadeh L,
Tajbakhsh A, Seifi S, Moetamani-Ahmadi M, Ferns GA and Avan A: The
prognostic and therapeutic values of long noncoding RNA PANDAR in
colorectal cancer. J Cell Physiol. 234:1230–1236. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wei L, Wang X, Lv L, Zheng Y, Zhang N and
Yang M: The emerging role of noncoding RNAs in colorectal cancer
chemoresistance. Cell Oncol (Dordr). 42:757–768. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gao N, Li Y, Li J, Gao Z, Yang Z, Li Y,
Liu H and Fan T: Long non-coding RNAs: The regulatory mechanisms,
research strategies, and future directions in cancers. Front Oncol.
10:5988172020. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Samimi H, Sajjadi-Jazi SM, Seifirad S,
Atlasi R, Mahmoodzadeh H, Faghihi MA and Haghpanah V: Molecular
mechanisms of long non-coding RNAs in anaplastic thyroid cancer: A
systematic review. Cancer Cell International. 20:3522020.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Qi X, Zhang DH, Wu N, Xiao JH, Wang X and
Ma W: ceRNA in cancer: Possible functions and clinical
implications. J Med Genet. 52:710–718. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ergun S and Oztuzcu S: Oncocers:
ceRNA-mediated cross-talk by sponging miRNAs in oncogenic pathways.
Tumour Biol. 36:3129–3136. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Das S and Bhattacharyya NP: Heat shock
factor 1 regulates hsa-miR-432 expression in human cervical cancer
cell line. Biochem Biophys Res Commun. 453:461–466. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jiang N, Chen WJ, Zhang JW, Xu C, Zeng XC,
Zhang T, Li Y and Wang GY: Downregulation of miR-432 activates
Wnt/β-catenin signaling and promotes human hepatocellular carcinoma
proliferation. Oncotarget. 6:7866–7879. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chen L, Kong G, Zhang C, Dong H, Yang C,
Song G, Guo C, Wang L and Yu H: MicroRNA-432 functions as a tumor
suppressor gene through targeting E2F3 and AXL in lung
adenocarcinoma. Oncotarget. 7:20041–20053. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Luo M, Hu Z, Kong Y and Li L:
MicroRNA-432-5p inhibits cell migration and invasion by targeting
CXCL5 in colorectal cancer. Exp Ther Med. 21:3012021. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lian J, Tang J, Shi H, Li H, Zhen T, Xie
W, Zhang F, Yang Y and Han A: Positive feedback loop of
hepatoma-derived growth factor and beta-catenin promotes
carcinogenesis of colorectal cancer. Oncotarget. 6:29357–29374.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liao F, Liu M, Lv L and Dong W:
Hepatoma-derived growth factor promotes the resistance to
anti-tumor effects of nordihydroguaiaretic acid in colorectal
cancer cells. Eur J Pharmacol. 645:55–62. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hu TH, Lin JW, Chen HH, Liu LF, Chuah SK
and Tai MH: The expression and prognostic role of hepatoma-derived
growth factor in colorectal stromal tumors. Dis Colon Rectum.
52:319–326. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Liao F, Dong W and Fan L: Apoptosis of
human colorectal carcinoma cells is induced by blocking
hepatoma-derived growth factor. Med Oncol. 27:1219–1226. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hong YG, Huang ZP, Liu QZ, E JF, Gao XH,
Xin C, Zhang W, Li P and Hao LQ: MicroRNA-95-3p inhibits cell
proliferation and metastasis in colorectal carcinoma by HDGF.
Biomed J. 43:163–173. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
He S, Wang G, Ni J, Zhuang J, Zhuang S,
Wang G, Ye Y and Xia W: MicroRNA-511 inhibits cellular
proliferation and invasion in colorectal cancer by directly
targeting hepatoma-derived growth factor. Oncol Res. 26:1355–1363.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Sun B, Gu X, Chen Z and Xiang J: MiR-610
inhibits cell proliferation and invasion in colorectal cancer by
repressing hepatoma-derived growth factor. Am J Cancer Res.
5:3635–3644. 2015.PubMed/NCBI
|
